Treatment Plan for Iron Deficiency Anemia in a 49-Year-Old Female
The patient should be treated with oral ferrous sulfate 60-120 mg of elemental iron daily (equivalent to 324 mg ferrous sulfate tablet taken 1-2 times daily) and investigated for underlying causes of iron deficiency anemia, particularly gastrointestinal sources of blood loss. 1
Diagnosis Confirmation
The laboratory results clearly indicate iron deficiency anemia:
- Low iron saturation (14%, reference range 20-55%)
- High TIBC (451 mcg/dL, reference range 228-428 mcg/dL)
- Low ferritin (15 ng/mL, just at the lower limit of normal range 11-336 ng/mL)
- Normal hemoglobin (12.6 g/dL) but with laboratory evidence of iron deficiency
The AGA recommends using a ferritin cutoff of 45 ng/mL for diagnosing iron deficiency, and this patient's ferritin of 15 ng/mL is well below this threshold. 1
Treatment Algorithm
1. Iron Supplementation
First-line therapy: Oral ferrous sulfate 324 mg (65 mg elemental iron) 1-2 times daily 1, 2
- This provides 65-130 mg of elemental iron daily, within the recommended range of 60-120 mg/day
- Take on an empty stomach if tolerated, with vitamin C to enhance absorption
- Common side effects include constipation, nausea, and black stools
Monitoring response:
Alternative options if oral iron is not tolerated:
2. Diagnostic Workup for Underlying Cause
Since the patient is 49 years old, a thorough investigation for the source of iron deficiency is warranted:
Bidirectional endoscopy (upper endoscopy and colonoscopy) is strongly recommended for postmenopausal women and men with iron deficiency anemia 1
- At age 49, the patient is approaching menopause, and the risk of significant GI pathology increases with age
- Upper endoscopy should include duodenal biopsies to rule out celiac disease
Additional testing:
Follow-up Plan
- Monitor hemoglobin and red cell indices at 4 weeks to assess response to iron therapy
- If hemoglobin increases by <1.0 g/dL at 2 weeks, consider switching to IV iron 3
- Once normal, monitor hemoglobin and red cell indices every 3 months for one year, then after a further year 1
- Additional oral iron should be given if hemoglobin or MCV falls below normal
- Further investigation is necessary if hemoglobin cannot be maintained with iron supplementation
Common Pitfalls and Caveats
- Inadequate dosing: Many providers prescribe insufficient elemental iron doses; ensure 60-120 mg of elemental iron daily
- Premature discontinuation: Iron therapy should continue for 3 months after correction of anemia to replenish iron stores
- Failure to investigate: In a 49-year-old woman, gastrointestinal causes of blood loss must be ruled out, even if menstrual bleeding is present
- Poor adherence: Side effects often lead to non-compliance; discuss strategies to improve tolerance (taking with food if needed, despite reduced absorption)
- Misdiagnosis: Anemia of chronic disease can be mistaken for iron deficiency; the high TIBC in this case confirms true iron deficiency
By following this treatment plan, the patient's iron deficiency anemia should resolve within 3-4 months, while the diagnostic workup will help identify and address any underlying causes to prevent recurrence.